Developer docs
API playgroundTry for free, no card

Search company profiles

RIVANNA

Full company profile

uuid000055f

Namestring
RIVANNA
Legal namestring
Rivanna Medical, Inc.
Company typeenum
Private
Founded yearint
2010
Short descriptiontext

RIVANNA is a Charlottesville, VA-based medical device company that develops AI-powered ultrasound imaging systems for spinal anesthesia guidance and point-of-care musculoskeletal fracture triage, selling the FDA-cleared Accuro, Accuro 3S, and Accuro XV platforms to hospitals and academic medical centers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCharlottesville, United States
HQ citystring
Charlottesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
point-of-care ultrasound, AI medical imaging, spinal needle guidance, musculoskeletal ultrasound systems, radiation-free diagnostics
Industry4 codes
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Point-of-Care Ultrasound Imaging Systems
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of Accuro ultrasound systems including Accuro 3S and Accuro XV platforms along with supporting equipment and components

rivannamedical.com
2Consumables
TypeHardware Sales
Description

Single-use sterile components including the Accuro 3S Needle Guide Kit and probe covers for infection control and procedural support

rivannamedical.com
3Service and Support
TypeProfessional Services
Description

Product repair, replacement, and service plans including software upgrades and warranty coverage

rivannamedical.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Accuro
Description

AI-powered ultrasound guidance platform for spinal needle interventions and musculoskeletal diagnostics.

rivannamedical.com
+7 more records
Core offering1 text field

RIVANNA develops, manufactures, and sells AI-powered point-of-care ultrasound imaging systems that replace X-ray-based medical imaging. Its core products are the Accuro 3S handheld/cart diagnostic ultrasound system with integrated SpineNav-AI software for neuraxial anesthesia guidance, the Accuro XV cart-based volumetric ultrasound imaging system for musculoskeletal and fracture detection, and supporting consumables (Accuro 3S Needle Guide Kit, Accuro Locator Kit). The systems use a patented Dual-Array probe and SafeTrack needle tracking to automate spinal landmark detection and bone visualization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • First-attempt success rate improved to 72.5% vs 40.0% with palpation in obese patients undergoing cesarean delivery
+6 more records
Product overview1 text field

RIVANNA offers a unified AI imaging platform powering two purpose-built product assets for point-of-care diagnostics. The core portfolio includes the original Accuro and Accuro 3S handheld ultrasound systems for neuraxial anesthesia guidance (featuring Dual-Array probe technology, SafeTrack needle tracking, and SpineNav-AI/BoneEnhance software), and Accuro XV cart-based volumetric ultrasound for musculoskeletal/fracture imaging. Supporting consumables include the Accuro 3S Needle Guide Kit. AI capabilities include automated anatomical detection (SpineNav-AI), bone visualization (BoneEnhance), and automated fracture detection (CADe/x). All systems are FDA 510(k) cleared and validated across multiple academic medical centers.

Product and service5 records
1Accuro
CategoryPoint-of-care ultrasound imaging system
Description

Original RIVANNA handheld ultrasound-based spinal navigation system with automated measurements of spinal midline and epidural depth. Features BoneEnhance Multi-Frequency Image Reconstruction and SpineNav3D AI-Enabled Spine Recognition for real-time anatomical guidance during epidural and spinal anesthesia procedures; supports anesthesiologists, CRNAs, and obstetric anesthesia teams in difficult-anatomy patients.

2Accuro 3S
CategoryPoint-of-care diagnostic ultrasound system
Description

Next-generation portable, point-of-care ultrasound system with a proprietary Dual-Array convex probe and integrated SpineNav-AI software. Features touchscreen interface, maneuverable cart-based form factor, and DICOM-based healthcare IT connectivity for neuraxial anesthesia guidance; designed for anesthesiologists performing epidural and spinal anesthesia.

3Accuro XV
CategoryPoint-of-care volumetric ultrasound imaging system
Description

Cart-based point-of-care volumetric ultrasound imaging system for musculoskeletal imaging. Features a conformable 3D probe with automated large field-of-view B-mode acquisition, 10 cm scan extent, polyurethane stand-off medium, touchscreen interface, integrated battery, and DICOM compatibility; targets emergency medicine physicians for bedside fracture triage.

4Accuro 3S Needle Guide Kit
CategorySingle-use sterile consumable kit
Description

Single-use sterile consumable for use with the Accuro 3S and Dual-Array transducer. Includes a sterile patient drape with stabilization bands for hands-free transducer positioning and guided needle insertion, and a probe cover for infection control; supports a single-operator workflow for needle-based procedures.

5Accuro Locator Kit
CategorySingle-use consumable kit
Description

Consumable kit for use with the Accuro system to support ultrasound-guided needle-based procedures requiring disposable supplies.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-10-21
Description

Collaboration partner for CDMRP-funded development of Accuro 3S-MIL military-optimized portable ultrasound system for spinal interventions. The $3M grant aims to improve treatment accessibility for back pain and spinal injuries in military settings.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-14
Description

Academic collaborator alongside Virginia Commonwealth University for Virginia Catalyst-funded development of AI-enabled ultrasound platform for neuraxial anesthesia.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-14
Description

Academic collaborator alongside University of Virginia for Virginia Catalyst-funded development of AI-enabled ultrasound platform for neuraxial anesthesia.

4BOMImed
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-11-30
Description

Partnership with Canadian manufacturer of anesthesia and critical care consumables to increase distribution of Accuro in Canada.

rivannamedical.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-05-04
Description

Alliance with specialty distributor of respiratory, anesthesia, and critical-care supplies to increase nationwide distribution of Accuro in the United States.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2016-09-27
Description

UK-based distribution partner for international market adoption of Accuro in the United Kingdom.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor in AI-powered point-of-care ultrasound with handheld probes. Both companies target procedural guidance and diagnostic imaging at the bedside with AI-augmented devices, serving similar hospital and clinical markets.

TypeDirect peer
Description

Direct competitor in point-of-care ultrasound systems, particularly in emergency medicine and anesthesia. Both companies serve procedural guidance and bedside diagnostic use cases with portable ultrasound platforms.

TypeBroad incumbent
Description

Broad incumbent in medical imaging and ultrasound with comprehensive product portfolio. Competitor across multiple RIVANNA target segments with established hospital relationships and significantly larger sales infrastructure.

TypeBroad incumbent
Description

Broad incumbent in medical imaging and ultrasound. Competes in point-of-care and procedural guidance markets with established hospital channel and integrated AI imaging capabilities.

TypeBroad incumbent
Description

Broad incumbent in medical imaging with ultrasound and AI capabilities. Competes in radiology and emergency medicine imaging with established enterprise sales channels.

TypeDirect peer
Description

Direct competitor in handheld/portable ultrasound with AI-enhanced imaging for procedural guidance. Targets similar point-of-care markets including anesthesia, emergency medicine, and MSK applications.

TypeEmerging player
Description

Emerging player in AI-enabled point-of-care ultrasound. Competes in procedural guidance and bedside diagnostics with focus on AI-driven workflow improvements similar to RIVANNA's approach.

TypeEmerging player
Description

Emerging player in handheld ultrasound with AI imaging for point-of-care applications. Targets similar clinical segments including emergency medicine and procedural guidance.

TypeBroad incumbent
Description

Broad medical imaging incumbent with comprehensive ultrasound portfolio including point-of-care systems. Competes in anesthesia, emergency medicine, and MSK imaging segments.

TypeEmerging player
Description

Specialized ultrasound competitor in surgical and procedural guidance, including intraoperative imaging. Now part of GE HealthCare, competes in image-guided procedures similar to RIVANNA's procedural guidance focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RIVANNA

Point-of-Care Ultrasound Imaging Systemsrivannamedical.com

RIVANNA is a Charlottesville, VA-based medical device company that develops AI-powered ultrasound imaging systems for spinal anesthesia guidance and point-of-care musculoskeletal fracture triage, selling the FDA-cleared Accuro, Accuro 3S, and Accuro XV platforms to hospitals and academic medical centers.

RIVANNA firmographics

Firmographics
Name
RIVANNA
Legal name
Rivanna Medical, Inc.
Website
https://rivannamedical.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
51–100 employees
Short description
RIVANNA is a Charlottesville, VA-based medical device company that develops AI-powered ultrasound imaging systems for spinal anesthesia guidance and point-of-care musculoskeletal fracture triage, selling the FDA-cleared Accuro, Accuro 3S, and Accuro XV platforms to hospitals and academic medical centers.
Ownership category
akta.pro rank

RIVANNA industry classification

Industry
Product category
Point-of-Care Ultrasound Imaging Systems
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Point-of-care ultrasound
  • AI medical imaging
  • Spinal needle guidance
  • Musculoskeletal ultrasound systems
  • Radiation-free diagnostics

Where RIVANNA is headquartered

Location

Headquarters

HQ city
Charlottesville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RIVANNA business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Hardware Sales: Sale of Accuro ultrasound systems including Accuro 3S and Accuro XV platforms along with supporting equipment and components
  2. Consumables: Single-use sterile components including the Accuro 3S Needle Guide Kit and probe covers for infection control and procedural support
  3. Service and Support: Product repair, replacement, and service plans including software upgrades and warranty coverage

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

RIVANNA product offering

Product offering

Core offering

RIVANNA develops, manufactures, and sells AI-powered point-of-care ultrasound imaging systems that replace X-ray-based medical imaging. Its core products are the Accuro 3S handheld/cart diagnostic ultrasound system with integrated SpineNav-AI software for neuraxial anesthesia guidance, the Accuro XV cart-based volumetric ultrasound imaging system for musculoskeletal and fracture detection, and supporting consumables (Accuro 3S Needle Guide Kit, Accuro Locator Kit). The systems use a patented Dual-Array probe and SafeTrack needle tracking to automate spinal landmark detection and bone visualization.

Product overview

RIVANNA offers a unified AI imaging platform powering two purpose-built product assets for point-of-care diagnostics. The core portfolio includes the original Accuro and Accuro 3S handheld ultrasound systems for neuraxial anesthesia guidance (featuring Dual-Array probe technology, SafeTrack needle tracking, and SpineNav-AI/BoneEnhance software), and Accuro XV cart-based volumetric ultrasound for musculoskeletal/fracture imaging. Supporting consumables include the Accuro 3S Needle Guide Kit. AI capabilities include automated anatomical detection (SpineNav-AI), bone visualization (BoneEnhance), and automated fracture detection (CADe/x). All systems are FDA 510(k) cleared and validated across multiple academic medical centers.

Differentiator

Problem solved

Functional benefit

Brands

  • Accuro: AI-powered ultrasound guidance platform for spinal needle interventions and musculoskeletal diagnostics.
  • Accuro 3S
  • Accuro XV
  • BoneEnhance
  • SpineNav-AI
  • SpineNav3D
  • SafeTrack
  • Dual-Array

Products and services

  • Accuro Original RIVANNA handheld ultrasound-based spinal navigation system with automated measurements of spinal midline and epidural depth. Features BoneEnhance Multi-Frequency Image Reconstruction and SpineNav3D AI-Enabled Spine Recognition for real-time anatomical guidance during epidural and spinal anesthesia procedures; supports anesthesiologists, CRNAs, and obstetric anesthesia teams in difficult-anatomy patients.
  • Accuro 3S Next-generation portable, point-of-care ultrasound system with a proprietary Dual-Array convex probe and integrated SpineNav-AI software. Features touchscreen interface, maneuverable cart-based form factor, and DICOM-based healthcare IT connectivity for neuraxial anesthesia guidance; designed for anesthesiologists performing epidural and spinal anesthesia.
  • Accuro XV Cart-based point-of-care volumetric ultrasound imaging system for musculoskeletal imaging. Features a conformable 3D probe with automated large field-of-view B-mode acquisition, 10 cm scan extent, polyurethane stand-off medium, touchscreen interface, integrated battery, and DICOM compatibility; targets emergency medicine physicians for bedside fracture triage.
  • Accuro 3S Needle Guide Kit Single-use sterile consumable for use with the Accuro 3S and Dual-Array transducer. Includes a sterile patient drape with stabilization bands for hands-free transducer positioning and guided needle insertion, and a probe cover for infection control; supports a single-operator workflow for needle-based procedures.
  • Accuro Locator Kit Consumable kit for use with the Accuro system to support ultrasound-guided needle-based procedures requiring disposable supplies.

Quantifiable outcome

  • First-attempt success rate improved to 72.5% vs 40.0% with palpation in obese patients undergoing cesarean delivery
  • +6 more outcomes

Companies that use RIVANNA

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles3 records

RIVANNA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability9 records

Feature8 records

RIVANNA partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered major, core and minor.

  • The Geneva FoundationmajorStrategic or Co-development Partner · 21 October 2025Collaboration partner for CDMRP-funded development of Accuro 3S-MIL military-optimized portable ultrasound system for spinal interventions. The $3M grant aims to improve treatment accessibility for back pain and spinal injuries in military settings.
  • University of VirginiacoreStrategic or Co-development Partner · 14 August 2025Academic collaborator alongside Virginia Commonwealth University for Virginia Catalyst-funded development of AI-enabled ultrasound platform for neuraxial anesthesia.
  • Virginia Commonwealth UniversitycoreStrategic or Co-development Partner · 14 August 2025Academic collaborator alongside University of Virginia for Virginia Catalyst-funded development of AI-enabled ultrasound platform for neuraxial anesthesia.
  • BOMImedcoreChannel Partner/ Reseller/ Distributor · 30 November 2021Partnership with Canadian manufacturer of anesthesia and critical care consumables to increase distribution of Accuro in Canada.
  • Tri-anim Health ServicescoreChannel Partner/ Reseller/ Distributor · 4 May 2021Alliance with specialty distributor of respiratory, anesthesia, and critical-care supplies to increase nationwide distribution of Accuro in the United States.
  • Vertec ScientificminorChannel Partner/ Reseller/ Distributor · 27 September 2016UK-based distribution partner for international market adoption of Accuro in the United Kingdom.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

RIVANNA competitors and assessment

Company assessment

Direct peers

  • Butterfly Network: Direct competitor in AI-powered point-of-care ultrasound with handheld probes. Both companies target procedural guidance and diagnostic imaging at the bedside with AI-augmented devices, serving similar hospital and clinical markets.
  • FUJIFILM Sonosite: Direct competitor in point-of-care ultrasound systems, particularly in emergency medicine and anesthesia. Both companies serve procedural guidance and bedside diagnostic use cases with portable ultrasound platforms.
  • Clarius Mobile Health: Direct competitor in handheld/portable ultrasound with AI-enhanced imaging for procedural guidance. Targets similar point-of-care markets including anesthesia, emergency medicine, and MSK applications.

Broad incumbents

  • GE HealthCare: Broad incumbent in medical imaging and ultrasound with comprehensive product portfolio. Competitor across multiple RIVANNA target segments with established hospital relationships and significantly larger sales infrastructure.
  • Philips Healthcare: Broad incumbent in medical imaging and ultrasound. Competes in point-of-care and procedural guidance markets with established hospital channel and integrated AI imaging capabilities.
  • Siemens Healthineers: Broad incumbent in medical imaging with ultrasound and AI capabilities. Competes in radiology and emergency medicine imaging with established enterprise sales channels.
  • Mindray: Broad medical imaging incumbent with comprehensive ultrasound portfolio including point-of-care systems. Competes in anesthesia, emergency medicine, and MSK imaging segments.

Emerging players

  • EchoNous: Emerging player in AI-enabled point-of-care ultrasound. Competes in procedural guidance and bedside diagnostics with focus on AI-driven workflow improvements similar to RIVANNA's approach.
  • Exo Imaging: Emerging player in handheld ultrasound with AI imaging for point-of-care applications. Targets similar clinical segments including emergency medicine and procedural guidance.
  • BK Medical (GE HealthCare): Specialized ultrasound competitor in surgical and procedural guidance, including intraoperative imaging. Now part of GE HealthCare, competes in image-guided procedures similar to RIVANNA's procedural guidance focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

RIVANNA social profiles

Digital presence

RIVANNA compliance and trust

Trust signal

Compliance2 records

RIVANNA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RIVANNA leadership team

Management profile

Number of profiles

Profiles9 records

RIVANNA funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RIVANNA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RIVANNA

What does RIVANNA do?

RIVANNA develops, manufactures, and sells AI-powered point-of-care ultrasound imaging systems that replace X-ray-based medical imaging. Its core products are the Accuro 3S handheld/cart diagnostic ultrasound system with integrated SpineNav-AI software for neuraxial anesthesia guidance, the Accuro XV cart-based volumetric ultrasound imaging system for musculoskeletal and fracture detection, and supporting consumables (Accuro 3S Needle Guide Kit, Accuro Locator Kit). The systems use a patented Dual-Array probe and SafeTrack needle tracking to automate spinal landmark detection and bone visualization.

Is RIVANNA a public or private company?

RIVANNA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RIVANNA founded?

RIVANNA was founded in 2010. It employs 51 to 100 people.

Where is RIVANNA based?

RIVANNA is headquartered in Charlottesville, United States, in the North America region.

How does RIVANNA make money?

Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are consumables and service and Support.

Who are RIVANNA's main competitors?

Direct peers on record are Butterfly Network, FUJIFILM Sonosite and Clarius Mobile Health. Broad incumbents are GE HealthCare, Philips Healthcare, Siemens Healthineers and Mindray. Emerging players are EchoNous, Exo Imaging and BK Medical (GE HealthCare).

Does RIVANNA have an API?

No public API is recorded for RIVANNA.

What industry is RIVANNA in?

RIVANNA's product category is Point-of-Care Ultrasound Imaging Systems. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Unite.AIRIVANNA Wins FDA Clearance for BoneEnhance AI Module on Accuro XVRIVANNA received FDA 510(k) clearance for BoneEnhance, a machine learning module for its Accuro XV ultrasound system, on October 22, 2026. The module segments bone and tissues, with validation showing 95.1% to 100% per-volume label prediction accuracy. The clearance supports development of an investigational injury detection module.PR NewswireFDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA's Accuro XV platformRIVANNA received FDA 510(k) clearance for BoneEnhance, a machine learning module for its Accuro XV ultrasound system that segments bone and tissues. Validation showed per-volume label prediction accuracy of 95.1% to 100% across 233 datasets. An injury detection module is in development.PR NewswireRIVANNA crosses 100-patent threshold: estate protects shared platform spanning multiple FDA-cleared product linesRIVANNA announced its 100th patent filing, an AI-powered ultrasound pathology detection pipeline for the Accuro XV platform. The estate spans 100+ patents across 20+ families, growing 30% year-over-year, and protects shared hardware, AI, and data across FDA-cleared Accuro 3S and Accuro XV. The filing advances toward FDA clearance for automated fracture detection.PR NewswireRIVANNA announces new CMS procedure code for computer-aided neuraxial guidanceCMS established ICD-10-PCS code XEZU3HC for computer-aided neuraxial guidance with ultrasound and needle tracking, effective Oct 1, 2026. The code makes the procedure separately reportable in inpatient data, enabling outcome evaluation. RIVANNA plans to include it in its outcomes framework in Q4 2026.RuntimewireCMS creates a neuraxial ultrasound code after RIVANNA's push, payment not includedCMS created ICD-10-PCS code XEZU3HC for computer-aided ultrasound navigation and continuous needle tracking during neuraxial anesthesia, effective October 1. The code provides no separate payment, only visibility for hospitals to record use. RIVANNA plans to add it to an outcomes framework in Q4 2026.TodaysmedicaldevelopmentsRegulatory roundup – May 2026Multiple medical device companies received FDA 510(k) clearances in May 2026, spanning AI-powered imaging platforms, surgical navigation systems, ablation generators, and diagnostic ultrasound devices. Abbott secured both FDA clearance and CE Mark for its Ultreon 3.0 coronary imaging software, while Siemens Healthineers cleared six new Artis interventional imaging systems featuring AI-based Optiq imaging technology. The roundup also includes FDA clearances for Galvanize Therapeutics' Aliya EX surgical ablation generator, Corvention's KardiaPSI balloon catheter, ZETA SURGICAL's neurosurgical navigation system, RIVANNA's Accuro XV diagnostic ultrasound, Pixee Medical's Knee+ NexSight AR surgical system, and Chest Wall Innovations' PC Fix rib fixation system.Diagnostic ImagingAccuro XV Musculoskeletal Ultrasound Device Garners FDA ClearanceThe FDA granted 510(k) clearance for Rivanna's Accuro XV musculoskeletal ultrasound system, a cart-based device designed for point-of-care extremity imaging. A 205-patient study published in the Journal of Emergency Medicine demonstrated that non-physician operators achieved diagnostically adequate images at a greater than 90 percent rate after just one hour of training, comparable to board-certified emergency physicians. Rivanna indicated plans to add AI-powered bone visualization (BoneEnhance) and automated fracture identification (CADe/x) capabilities to the platform in the future.Medical Device NetworkFDA greenlights Rivanna’s AI musculoskeletal imaging systemRivanna, a Virginia-based medical device company, has received FDA clearance for its Accuro XV AI-based musculoskeletal imaging system, which uses ultrasound and AI to automate detection and assessment of fractures and soft tissue injuries at the point-of-care. The system is designed for emergency departments to streamline triage of low-severity extremity injuries and reduce reliance on x-ray referrals. The clearance positions Rivanna to commercialize the system across US hospitals and medical clinics, with the company planning to develop additional AI capabilities including BoneEnhance and CADe/x algorithms.BioSpaceRIVANNA receives FDA 510(k) clearance for Accuro XV musculoskeletal ultrasound imaging systemRIVANNA received FDA 510(k) clearance for its Accuro XV musculoskeletal ultrasound system, authorizing commercial use in hospital and clinic settings. The clearance enables AI modules like BoneEnhance and CADe/x for bone visualization and fracture detection, with validation from an eight-center clinical study. The company plans to accelerate these AI capabilities.AuntMinnieRivanna gets FDA nod for Accuro XV diagnostic ultrasound platformRivanna has obtained FDA 510(k) clearance for its Accuro XV diagnostic ultrasound system, which features a volumetric probe and AI-enabled capabilities like BoneEnhance. The platform is designed to automate image acquisition and improve acoustic coupling with irregular anatomies. The software is currently undergoing validation through a multisite clinical study at eight academic medical centers.